{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T20:37:12Z","timestamp":1762979832713},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.juro.2011.03.134","type":"journal-article","created":{"date-parts":[[2011,6,23]],"date-time":"2011-06-23T23:48:01Z","timestamp":1308872881000},"page":"442-447","source":"Crossref","is-referenced-by-count":11,"title":["Clinical Predictive Factors of Poor Outcome in Patients With Stage pT0 Disease at Radical Cystectomy"],"prefix":"10.1097","volume":"186","author":[{"given":"Oscar","family":"Rodriguez Faba","sequence":"first","affiliation":[{"name":"Department of Urology and Section of Pathology (FA), Universitat Autonoma de Barcelona, Fundaci\u00f3 Puigvert, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Palou","sequence":"additional","affiliation":[{"name":"Department of Urology and Section of Pathology (FA), Universitat Autonoma de Barcelona, Fundaci\u00f3 Puigvert, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Rosales","sequence":"additional","affiliation":[{"name":"Department of Urology and Section of Pathology (FA), Universitat Autonoma de Barcelona, Fundaci\u00f3 Puigvert, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Breda","sequence":"additional","affiliation":[{"name":"Department of Urology and Section of Pathology (FA), Universitat Autonoma de Barcelona, Fundaci\u00f3 Puigvert, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferran","family":"Algaba","sequence":"additional","affiliation":[{"name":"Department of Urology and Section of Pathology (FA), Universitat Autonoma de Barcelona, Fundaci\u00f3 Puigvert, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillermo","family":"Urdaneta","sequence":"additional","affiliation":[{"name":"Department of Urology and Section of Pathology (FA), Universitat Autonoma de Barcelona, Fundaci\u00f3 Puigvert, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Humberto","family":"Villavicencio","sequence":"additional","affiliation":[{"name":"Department of Urology and Section of Pathology (FA), Universitat Autonoma de Barcelona, Fundaci\u00f3 Puigvert, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2011.03.134_bib1","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jamcollsurg.2005.09.009","article-title":"Gender and geographic influence on the racial disparity in bladder cancer mortality in the US","volume":"202","author":"Underwood","year":"2006","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.juro.2011.03.134_bib2","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0022-5347(05)66440-3","article-title":"Cystectomy for bladder cancer: a contemporary series","volume":"165","author":"Dalbagni","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2011.03.134_bib3","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/S0022-5347(05)00995-X","article-title":"Cancer specific outcomes in patients with pT0 disease following radical cystectomy","volume":"175","author":"Palapattu","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2011.03.134_bib4","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.eururo.2007.03.086","article-title":"P0 stage at radical cystectomy for bladder cancer is associated with improved outcome independent of traditional clinical risk factors","volume":"52","author":"Kasouff","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2011.03.134_bib5","first-page":"763","article-title":"Stage pT0 bladder tumors after radical cystectomy: a review of our series","volume":"30","author":"Mallen Mateo","year":"2006","journal-title":"Actas Urol Esp"},{"key":"10.1016\/j.juro.2011.03.134_bib6","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.juro.2010.04.081","article-title":"Stage pT0 at radical cystectomy confers improved survival: an international study of 4,430 patients","volume":"184","author":"Tilki","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2011.03.134_bib7","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.eururo.2003.09.018","article-title":"Handling and pathology reporting of specimens with carcinoma of the urinary bladder, ureter, and renal pelvis","volume":"45","author":"Lopez-Beltran","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2011.03.134_bib8","first-page":"36","article-title":"Chemotherapy for local treatment of bladder cancer","volume":"15","author":"Stemberg","year":"2005","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.juro.2011.03.134_bib9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0022-5347(17)38244-7","article-title":"Results of contemporary radical cystectomy for invasive bladder cancer: a clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification","volume":"145","author":"Pagano","year":"1991","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2011.03.134_bib10","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0022-5347(17)32746-5","article-title":"Does a stage pT0 specimen confer a survival advantage in patients with minimally invasive bladder cancer?","volume":"152","author":"Thrasher","year":"1994","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2011.03.134_bib11","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1002\/cncr.21475","article-title":"Effect of a pT0 cystectomy specimen without neoadjuvant therapy on survival","volume":"104","author":"Volkmer","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.juro.2011.03.134_bib12","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1016\/j.juro.2009.08.083","article-title":"Lymphovascular invasion in transurethral resection specimens as predictor of progression and metastasis in patients with newly diagnosed T1 bladder urothelial cancer","volume":"182","author":"Cho","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2011.03.134_bib13","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.eururo.2003.10.006","article-title":"Prognosis of muscle-invasive bladder cancer: difference between primary and progressive tumours and implications for therapy","volume":"45","author":"Schrier","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2011.03.134_bib14","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S0022-5347(05)67280-1","article-title":"Primary superficial bladder cancer risk groups according to progression, mortality and recurrence","volume":"164","author":"Mill\u00e1n-Rodr\u00edguez","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2011.03.134_bib15","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/01.ju.0000032474.22093.06","article-title":"Superiority of ratio based lymph node staging for bladder cancer","volume":"169","author":"Herr","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2011.03.134_bib16","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1056\/NEJMoa022148","article-title":"Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer","volume":"349","author":"Grossman","year":"2003","journal-title":"N Engl J Med"},{"issue":"suppl","key":"10.1016\/j.juro.2011.03.134_bib17","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.urology.2006.10.041","article-title":"Chemotherapy for bladder cancer: treatment guidelines for neoadjuvant chemotherapy, bladder preservation, adjuvant chemotherapy, and metastatic cancer","volume":"69","author":"Sternberg","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.juro.2011.03.134_bib18","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1111\/j.1464-410X.2010.09574.x","article-title":"Induction chemotherapy for unresectable urothelial carcinoma of the bladder","volume":"107","author":"Ghadjar","year":"2011","journal-title":"BJU Int"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534711035476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534711035476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2011.03.134","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T02:15:32Z","timestamp":1651198532000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2011.03.134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["10.1016\/j.juro.2011.03.134"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2011.03.134","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}